• Movie

    Click here for the video of Kyoto.

  • Important Dates:

    On-site registration
    Available for the Congress, Post-Congress Meeting, Congress Dinner, Social Event Tickets for accompanying person, Roundtable Discussion, Japanese Cultural Program and YS Night Out.

    September 23, 2017
    Deadline of e-mail application for the Roundtable Discussion.

    September 18, 2017
    Deadline of online applications for the Post-Congress Meeting, Congress Dinner, Social Event Tickets for accompanying person, Japanese Cultural Program and YS Night Out.

    September 11, 2017
    Deadline for the Local Poster Printing Service

    August 31, 2017
    Extended to September 11, 2017
    Deadline Advanced Registration

    June 30, 2017
    Extended to July 31, 2017
    Deadline Early Bird Registration

    May 21, 2017
    Deadline Late-Breaking Abstract Submission

    April 30, 2017
    Notification Abstract/Poster Presentations

    February 28, 2017
    March 14, 2017

    Deadline Abstract Submission

    December 1, 2016
    Registration Open
    Hotel Reservation Open

    October 18, 2016
    Abstract Submission Open

Roundtable Discussion -Meet the Expert-

Seats are still available! Don't miss this opportunity!

Venue: Room Swan, Kyoto International Conference Center
Fee: Ticket JPY1,000 for each roundtable discussion.
Breakfast is provided.
9 seats (8 seats for RT-27-5) are available for each and it is first come first served.
No refund will be made.

Tickets are still available for purchase.
Please click the “Buy Ticket” button below and send an e-mail with your name, registration number, and roundtable number that you would like to attend.
Buy Ticket

Monday, September 25    7:30am - 8:30am

RT-25-1

Eberhard Wieland
Klinikum Stuttgart, Germany
Lymphocyte surface molecules as immune activation biomarkers in solid organ transplantation
(9-seat available)

RT-25-2

Hartmut Derendorf
University of Florida, USA
How to write a good article
(9-seat available)

RT-25-3

Roger Jelliffe
University of Southern California, USA
Individualized drug therapy
(9-seat available)

RT-25-4

Michael N. Neely
Children's Hospital Los Angeles, USA
Optimal sampling and dosing for individual patients
(9-seat available)

RT-25-5

Philip Patsalos
University College London, UK
Antiepileptic drug TDM: Current practice and future prospectives
(9-seat available)

RT-25-6

Shinya Ito
The Hospital for Sick Children, Canada
Drug monitoring in pregnancy and lactation
(9-seat available)

RT-25-7

Vanessa Steenkamp
University of Pretoria, South Africa
Assay and screening for drug abuse
(9-seat available)

RT-25-8

William Clarke
Johns Hopkins University School of Medicine, USA
Development and validation of clinical LC-MS assays – Consensus guidelines from CLSI
(9-seat available)

Tuesday, September 26    7:30am - 8:30am

RT-26-1

Alexander Vinks
Cincinnati Children’s Hospital Medical Center, USA
Precision medicine in pediatrics
(9-seat available)

RT-26-2Fully Booked

Etienne Chatelut
Institut Universitaire du Cancer de Toulouse, France
Clinical pharmacology of anticancer agents: benefits and limits of TDM

RT-26-3

Hans Maurer
Saarland University, Germany
Clinical or forensic toxicology – What''s the difference?
(9-seat available)

RT-26-4

Ikumi Tamai
Kanazawa University, Japan
Systemic effect of hepatic transporter and enzyme interplay
(9-seat available)

RT-26-5

Kamisha Johnson-Davis
University of Utah, c/o ARUP Laboratories, USA
Cannabis
(9-seat available)

RT-26-6

Mercè Brunet
Hospital Clínic of Barcelona, Spain
What we must improve to be able to implement biomarkers that facilitate a personalized immunosuppression?
(9-seat available)

RT-26-7

Uwe Christians
University of Colorado, USA
Therapeutic drug monitoring - A journal of personalized drug therapy
(9-seat available)

Wednesday, September 27    7:30am - 8:30am

RT-27-1

Charles Arthur Peloquin
University of Florida, USA
TDM of anti-tuberculosis treatment
(9-seat available)

RT-27-2

Hirotoshi Echizen
Meiji Pharmaceutical University, Japan
Individualization of warfarin dosing
(9-seat available)

RT-27-3

Manuela Neuman
University of Toronto, Canada
Mitochondrial toxicity-liver toxicity
(9-seat available)

RT-27-4

Tomasz Pawinski
Medical University of Warsaw, Poland
Implication of pharmacokinetics of immunosuppressive agents on TDM
(9-seat available)

RT-27-5

Tsuyoshi Fukuda and Chie Emoto
Cincinnati Children's Hospital Medical Center, USA
Improving pediatric dosing through allometric scaling, PopPK and PBPK modeling
(8-seat available)

RT-27-6

Tsuyoshi Shiga
Tokyo Women's Medical University, Japan
Clinical uses of amiodarone
(9-seat available)

RT-27-7

Yasutsuna Sasaki
Showa University, Japan
Clinical trials for anticancer agents
(9-seat available)